CLINICAL USE OF LEVODOPA AND AMANTADINE IN PARKINSONS-DISEASE

被引：0

|

作者：

WALKER, JE

机构：

[1] VET ADM HOSP,DALLAS,TX 75216

[2] UNIV TEXAS,HLTH SCI CTR,DALLAS,TX

来源：

CLINICAL MEDICINE | 1975年 / 82卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：27 / 29

页数：3

相关论文

共 50 条

[21] PIGMENTATION IN PARKINSONS-DISEASE TREATED WITH LEVODOPA
GRAINGER, KM
LANCET, 1973, 1 (7794): : 97 - 98
[22] LEVODOPA THERAPY FEATURES IN PARKINSONS-DISEASE
POLLAK, P
GAZETTE MEDICALE, 1985, 92 (37): : 83 - 86
[23] DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE
BLIN, J
BONNET, AM
AGID, Y
NEUROLOGY, 1988, 38 (09) : 1410 - 1416
[24] BROMOCRIPTINE COMBINED WITH LEVODOPA IN PARKINSONS-DISEASE
GAUTHIER, G
DASILVA, AM
EUROPEAN NEUROLOGY, 1982, 21 (04) : 217 - 226
[25] BROMOCRIPTINE IN LIEU OF LEVODOPA FOR PARKINSONS-DISEASE
WODAK, J
STARK, R
GILLIGAN, B
MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 : 28 - 31
[26] PROGRESSION OF PARKINSONS-DISEASE WITHOUT LEVODOPA
GOETZ, CG
TANNER, CM
SHANNON, KM
NEUROLOGY, 1987, 37 (04) : 695 - 698
[27] FLUCTUATING LEVODOPA CONCENTRATIONS AND PARKINSONS-DISEASE
JUNCOS, J
SERRATI, C
FABBRINI, G
CHASE, TN
LANCET, 1985, 2 (8452): : 440 - 440
[28] METABOLIC PATTERNS AND CLINICAL RESPONSE TO LEVODOPA THERAPY IN PARKINSONS-DISEASE
MESSIHA, FS
KNOPP, W
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1973, 14 (04) : 565 - 571
[29] LEVODOPA IN PARKINSONS-DISEASE - EFFECT ON MORTALITY
MARTTILA, RJ
RINNE, UK
SONNINEN, V
ACTA NEUROLOGICA SCANDINAVICA, 1984, 69 : 45 - 46
[30] TRANSIENT LEVODOPA WITHDRAWAL IN PARKINSONS-DISEASE
MAESNER, JE
CLINICAL PHARMACY, 1987, 6 (01): : 22 - 22

← 1 2 3 4 5 →